Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

September 30, 2005

Conditions
Alzheimer's Disease
Interventions
DRUG

PYM50028

Trial Locations (1)

OX3 7JX

Oxford Project to Investigate Memory and Ageing, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Phytopharm

INDUSTRY

NCT00130429 - Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease | Biotech Hunter | Biotech Hunter